2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Lymphoma
13
Leukemia
13
Lymphoma, Follicular
12
Rectal Neoplasms
10
Prostatic Neoplasms
10
Colonic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Colorectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Non-Hodgkin
7
Lymphoma, B-Cell, Marginal Zone
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Hodgkin Disease
7
Congenital Abnormalities
7
Ovarian Neoplasms
6
Multiple Myeloma
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myeloid, Acute
6
Kidney Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Burkitt Lymphoma
6
Neuroblastoma
5
Myeloproliferative Disorders
5
Lymphoma, T-Cell, Cutaneous
5
Central Nervous System Neoplasms
5
Adenocarcinoma of Lung
5
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Amplified Fragment Length Polymorphism Analysis
×
Clear all
NCT00875238
2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
133 enrolled